A friend in R&D was moaning about how his CEO was forever loading new projects into R&D. “It just fouls things up”, he said, “The
Although there are many tools and methodologies available to support R&D and much best practice, this is not readily available to those in industry. Assessing
When I was an R&D manager I often used to face the situation John Shave describes in his introduction when I was asked to approve
Procter & Gamble is a global consumer products company, the R&D activities are strongly driven by consumer needs and as a result the clock speed
Large R&D centric businesses have a huge asset in the vast experience that exists in their leading scientists – every trick in the book should
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of
Making up a “Risk Register” at the beginning of an R&D project obviously makes a lot of sense. However, risk assessment is not easy. There
Intuition can be very powerful, but when faced with novel situations our intuition is surprisingly easily led astray. There’s a whole body of work on
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa
University spinout (USO) are an important source of innovation however concerns are raised about the mediocre survival rate in general and even a lower rate
Have your say / Follow us
R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation. www.radma.net
© Copyright R&D Today
All rights reserved.